Temporary pacing leads sales will expand through 2036, with cardiac pacing leads catheter at 95.3% of the product type category, transcatheter aortic valve replacement leading the application segment and transcatheter aortic valve replacement at 24.6% of product type sales in 2026. The market is projected to record a 3.5% CAGR between 2026 and 2036.